XTL Biopharmaceuticals Ltd (XTLB) stock chart

XTLBNasdaqPharmaceutical Preparations

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30

$1.66−0.05 (-2.64%)

Close on Nov 11, 2026Market cap $15.71MP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?